
Reset all filters
01 1Onglyza/Kombiglyze XR/Komboglyze
Saxagliptin/Saxagliptin+Metoprolol Hydrochloride
Main Therapeutic Indication : Diabetes
Currency : USD
2015 Revenue in Millions : 820
2014 Revenue in Millions : 786
Growth (%) : -4%